1Orthopaedic Research Laboratory, St. Michael's Hospital, Wellesley Central Site, University of Toronto, Ont.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Rheumatoid arthritis causes osteopenia and bone loss through increased osteoclast activity. Bisphosphonates, by inhibiting osteoclasts, show potential in treating bone loss and joint damage in rheumatoid arthritis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: